Anticholinergic Risk Scale and Resource Use After Elective Noncardiac Surgery
NCT ID: NCT03151616
Last Updated: 2025-01-10
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
244976 participants
OBSERVATIONAL
2003-04-01
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neurokinin Receptor Antagonist Associated to Ondansetron in PONV
NCT02357693
Prevention of Post-Operative Nausea and Vomiting With Propofol Infusion
NCT05759481
Implementation Study of the PostOperative Nausea and Vomiting Prediction Rule
NCT00293618
Intrathecal Atropine Versus Intravenous Ondasetron in Post Operative Nausea Due to Intrathecal Morphine
NCT05137288
Efficacy of Low Dose Promethazine for Postoperative Nausea and Vomiting
NCT01159548
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No anticholinergic exposure
People with an anticholinergic risk scale score of 0
No interventions assigned to this group
Moderate anticholinergic exposure
People with an anticholinergic risk scale score of 1-2
anticholinergic risk scale
Risk summation scale for grading and studying anticholinergic medication exposure
High anticholinergic exposure
People with an anticholinergic risk scale score of \>=3
anticholinergic risk scale
Risk summation scale for grading and studying anticholinergic medication exposure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
anticholinergic risk scale
Risk summation scale for grading and studying anticholinergic medication exposure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Intermediate to high risk elective noncardiac surgery
Exclusion Criteria
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ottawa Hospital Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dan McIsaac
Associate Scientist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ottawa Hospital Research Institute
Ottawa, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DM6
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.